Compare IRDM & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRDM | ATRC |
|---|---|---|
| Founded | 2000 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | N/A | 2005 |
| Metric | IRDM | ATRC |
|---|---|---|
| Price | $16.44 | $40.55 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | $27.60 | ★ $52.22 |
| AVG Volume (30 Days) | ★ 2.1M | 563.9K |
| Earning Date | 10-23-2025 | 10-29-2025 |
| Dividend Yield | ★ 3.62% | N/A |
| EPS Growth | ★ 22.73 | N/A |
| EPS | ★ 1.14 | N/A |
| Revenue | ★ $871,710,000.00 | $518,304,999.00 |
| Revenue This Year | $7.64 | $16.90 |
| Revenue Next Year | $1.70 | $12.29 |
| P/E Ratio | $14.61 | ★ N/A |
| Revenue Growth | 7.30 | ★ 15.80 |
| 52 Week Low | $15.65 | $28.29 |
| 52 Week High | $34.45 | $43.11 |
| Indicator | IRDM | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 40.68 | 62.00 |
| Support Level | $17.37 | $38.92 |
| Resistance Level | $19.32 | $42.60 |
| Average True Range (ATR) | 0.74 | 1.52 |
| MACD | -0.05 | 0.20 |
| Stochastic Oscillator | 11.95 | 74.89 |
Iridium Communications Inc is the commercial provider of communications services offering true globalised coverage, connecting people, organizations and assets to and from anywhere, in real time. The company is a provider of mobile voice and data communications services through a constellation of low earth-orbiting satellites. Iridium's solutions are ideally suited for industries such as maritime, aviation, government/military, emergency/humanitarian services, mining, forestry, oil and gas, heavy equipment, transportation, and utilities. Iridium also provides service to subscribers from the U.S. Department of Defense, as well as other civil and government agencies world-wide. The Company operates in one business segment, providing satellite communications services and products.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.